Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers

SMSJ TUCSON HOLDINGS LLC

NPI: 1811598121 · TUCSON, AZ 85756 · General Acute Care Hospital · NPI assigned 11/03/2020

$2.43M
Total Medicaid Paid
43,557
Total Claims
40,910
Beneficiaries
53
Codes Billed
2021-03
First Month
2024-12
Last Month

Provider Details

Authorized OfficialCORMIER, CRISTIAN (CFO)
NPI Enumeration Date11/03/2020

Related Entities

Other providers sharing the same authorized official: CORMIER, CRISTIAN

ProviderCityStateTotal Paid
SMSJ TUCSON HOLDINGS LLC TUCSON AZ $29.82M
SMSJ TUCSON HOLDINGS LLC TUCSON AZ $28.93M
SMSJ TUCSON HOLDINGS, LLC TUCSON AZ $2.95M
SMSJ TUCSON HOLDINGS, LLC TUCSON AZ $25K

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2021 5,067 $252K
2022 13,503 $709K
2023 14,895 $891K
2024 10,092 $574K

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
99283 Emergency department visit for the evaluation and management, moderate severity 6,142 5,791 $1.13M
99284 Emergency department visit for the evaluation and management, high severity 3,031 2,865 $718K
99285 Emergency department visit for the evaluation and management, high severity with immediate threat to life 1,261 1,197 $231K
74177 Computed tomography, abdomen and pelvis; with contrast material 311 302 $185K
99282 Emergency department visit for the evaluation and management, low to moderate severity 1,175 1,129 $98K
70450 Computed tomography, head or brain; without contrast material 143 141 $35K
96361 Intravenous infusion, hydration; each additional hour 1,357 1,235 $10K
74176 Computed tomography, abdomen and pelvis; without contrast material 31 27 $10K
99281 Emergency department visit for the evaluation and management, self-limited or minor 203 193 $7K
87633 Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets 26 26 $483.00
84484 602 503 $268.78
87804 Infectious agent antigen detection by immunoassay; Influenza, each type 2,010 1,961 $218.25
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 1,379 1,341 $175.00
71046 Radiologic examination, chest; 2 views 617 598 $162.78
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance 1,852 1,732 $111.71
87807 375 366 $91.03
71045 Radiologic examination, chest; single view 616 582 $79.41
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe 863 852 $28.07
81003 2,808 2,636 $4.59
J1885 Injection, ketorolac tromethamine, per 15 mg 1,476 1,369 $0.38
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour 324 309 $0.00
87077 69 67 $0.00
U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc 26 25 $0.00
87088 531 508 $0.00
80048 Basic metabolic panel (calcium, ionized) 33 29 $0.00
96375 Therapeutic injection; each additional sequential IV push 1,477 1,357 $0.00
80053 Comprehensive metabolic panel 3,215 2,931 $0.00
85025 Blood count; complete (CBC), automated, and automated differential WBC count 3,452 3,143 $0.00
82150 391 374 $0.00
83605 27 25 $0.00
J0696 Injection, ceftriaxone sodium, per 250 mg 55 54 $0.00
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction 69 56 $0.00
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular 764 717 $0.00
87430 1,366 1,329 $0.00
85379 84 80 $0.00
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe 26 26 $0.00
87070 516 495 $0.00
83690 13 13 $0.00
87205 16 16 $0.00
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine 13 13 $0.00
81025 1,599 1,516 $0.00
J2405 Injection, ondansetron hydrochloride, per 1 mg 1,267 1,172 $0.00
87186 69 64 $0.00
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report 1,067 978 $0.00
73610 12 12 $0.00
94664 90 81 $0.00
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml 593 571 $0.00
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour 15 15 $0.00
J2270 Injection, morphine sulfate, up to 10 mg 12 12 $0.00
73630 24 24 $0.00
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe 26 26 $0.00
90715 14 14 $0.00
J7120 Ringers lactate infusion, up to 1000 cc 24 12 $0.00